share_log

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target

Benzinga ·  Apr 10 10:16

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment